Clinical Trial Update: Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic Diarrhoea [Phase 1]

View source ↗

Summary

Phase 1 trial assessing chronic administration of Diosmectite (SMECTA) in subjects with chronic functional diarrhea of unknown origin has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Diarrhea of Unknown Origin

Drugs mentioned

• Diosmectite (SMECTA) (diosmectite)

Snippet

Sponsor: Ipsen | Conditions: Chronic Functional Diarrhea of Unknown Origin | Phase 1 | Status: COMPLETED | Results posted: 2019-03-11